Diethelm Wallwiener Selected Research

Methotrexate (Mexate)

6/2007	Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.
7/2002	Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diethelm Wallwiener Research Topics

Disease

85	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2002
62	Neoplasms (Cancer) 04/2024 - 01/2002
14	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 06/2003
11	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2003
5	Carcinogenesis 05/2015 - 07/2003
4	Circulating Neoplastic Cells 01/2024 - 03/2011
4	Inflammation (Inflammations) 12/2020 - 01/2003
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2020 - 09/2004
4	Hemorrhage 01/2020 - 08/2004
4	Stress Urinary Incontinence 05/2016 - 07/2006
3	Ovarian Epithelial Carcinoma 01/2021 - 03/2008
3	Endometrial Neoplasms (Endometrial Cancer) 01/2020 - 07/2014
3	Nausea 03/2018 - 07/2002
3	Alopecia (Baldness) 03/2018 - 07/2002
3	Vomiting 03/2018 - 07/2002
3	Neutropenia 09/2017 - 08/2004
3	Carcinoma (Carcinomatosis) 07/2013 - 04/2002
3	Wounds and Injuries (Trauma) 03/2012 - 07/2006
2	Infections 05/2016 - 06/2009
2	Disease Progression 01/2016 - 01/2007
2	Ectopic Pregnancy 10/2015 - 11/2008
2	Uterine Diseases (Endometrial Disease) 12/2014 - 11/2009
2	Residual Neoplasm 10/2013 - 01/2008
2	Thrombocytopenia (Thrombopenia) 06/2009 - 08/2004
2	Pathologic Complete Response 06/2009 - 12/2004
2	Ductal Carcinoma 05/2006 - 05/2006
2	Febrile Neutropenia 12/2004 - 08/2004

Drug/Important Bio-Agent (IBA)

21	Hormones (Hormone)IBA 10/2022 - 07/2002
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2002
11	Progesterone Receptors (Progesterone Receptor)IBA 12/2020 - 07/2005
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2004
9	Estrogen ReceptorsIBA 12/2020 - 07/2002
8	AntigensIBA 11/2017 - 06/2003
8	Estrogens (Estrogen)FDA Link 01/2016 - 07/2003
8	Estradiol (Delestrogen)FDA LinkGeneric 05/2015 - 07/2002
6	Keratins (Keratin)IBA 06/2018 - 07/2003
5	Aromatase InhibitorsIBA 02/2024 - 12/2004
5	Letrozole (Femara)FDA LinkGeneric 02/2024 - 02/2008
5	PlatinumIBA 01/2021 - 03/2008
5	Progestins (Progestagens)IBA 10/2008 - 07/2002
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2004
4	Epirubicin (Ellence)FDA LinkGeneric 07/2012 - 08/2004
4	Adenosine Triphosphate (ATP)IBA 07/2012 - 01/2004
4	Messenger RNA (mRNA)IBA 03/2012 - 07/2003
4	Estrogen Receptor alphaIBA 09/2010 - 01/2008
4	VaccinesIBA 07/2007 - 06/2003
3	Tamoxifen FDA LinkGeneric 12/2020 - 05/2006
3	pertuzumabIBA 11/2020 - 01/2019
3	Epithelial Cell Adhesion MoleculeIBA 01/2016 - 07/2003
3	Progesterone FDA LinkGeneric 01/2016 - 03/2003
3	Zoledronic Acid (Zometa)FDA Link 10/2013 - 01/2010
3	Fluorouracil (Carac)FDA LinkGeneric 07/2012 - 07/2002
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2012 - 07/2002
3	Protein Isoforms (Isoforms)IBA 09/2010 - 01/2008
3	Monoclonal AntibodiesIBA 01/2008 - 06/2003
3	HLA-A*02:01 antigenIBA 04/2006 - 07/2003
3	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 07/2005 - 07/2002
3	Norethindrone (Norethisterone)FDA LinkGeneric 07/2005 - 07/2002
2	Phenobarbital (Luminal)FDA Link 01/2022 - 04/2021
2	ArgonIBA 04/2020 - 01/2020
2	CytokinesIBA 01/2020 - 10/2008
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2020 - 01/2008
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 03/2008
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 01/2009
2	TabletsIBA 08/2017 - 01/2017
2	Diphosphonates (Bisphosphonates)IBA 10/2013 - 07/2012
2	Fas Ligand Protein (Fas Ligand)IBA 05/2013 - 01/2004
2	Docetaxel (Taxotere)FDA Link 07/2012 - 12/2004
2	Ki-67 Antigen (Ki 67 Antigen)IBA 09/2010 - 05/2008
2	AnthracyclinesIBA 09/2010 - 05/2008
2	taxaneIBA 09/2010 - 05/2008
2	Estrogen Receptor betaIBA 09/2010 - 02/2009
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2010 - 06/2007
2	GelsIBA 01/2008 - 11/2002
2	Methotrexate (Mexate)FDA LinkGeneric 06/2007 - 07/2002
2	Leuprolide (Lupron)FDA LinkGeneric 06/2007 - 07/2002
2	Acetates (Acetic Acid Esters)FDA Link 06/2007 - 07/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2006 - 07/2005
2	Peptides (Polypeptides)IBA 04/2006 - 02/2005
2	Differentiation AntigensIBA 02/2005 - 10/2003
2	Gemcitabine FDA Link 12/2004 - 08/2004

Therapy/Procedure

56	Therapeutics 04/2024 - 07/2003
23	Drug Therapy (Chemotherapy) 01/2021 - 07/2002
10	Neoadjuvant Therapy 06/2021 - 12/2004
5	Radiotherapy 01/2023 - 07/2003
5	Segmental Mastectomy (Lumpectomy) 06/2019 - 12/2004
4	Lymph Node Excision (Lymph Node Dissection) 10/2016 - 11/2011
4	Lasers (Laser) 09/2015 - 11/2002
3	Cytoreduction Surgical Procedures 01/2021 - 10/2011
3	Operative Surgical Procedures 04/2009 - 02/2005
3	Suburethral Slings (Tension-Free Vaginal Tape) 03/2007 - 07/2004
2	Transplantation 08/2020 - 01/2018
2	Ligation 01/2020 - 11/2009
2	Immunotherapy 11/2017 - 02/2005
2	Complementary Therapies (Alternative Medicine) 05/2017 - 01/2017
2	Adjuvant Chemotherapy 10/2016 - 07/2003
2	Hysterectomy 12/2014 - 07/2011
2	Hyperthermic Intraperitoneal Chemotherapy 06/2014 - 10/2011
2	Oncolytic Virotherapy 10/2011 - 02/2011
2	Conservative Treatment 09/2011 - 03/2007